The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProven Vct Regulatory News (PVN)

Share Price Information for Proven Vct (PVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.50
Bid: 58.00
Ask: 61.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.172%)
Open: 59.50
High: 59.50
Low: 59.50
Prev. Close: 59.50
PVN Live PriceLast checked at -
ProVen VCT is an Investment Trust

To achieve long-term returns from investing in a portfolio of quoted companies, qualifying investments in small and medium sized unquoted companies and non-qualifying investments permitted for liquidity management purposes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProVen VCT plc: Statement re. Offer for Subscription

3 Dec 2020 14:05

ProVen VCT plc: Statement re. Offer for Subscription

ProVen VCT plcProVen Growth and Income VCT plc3 December 2020Offer for Subscription

ProVen VCT plc and ProVen Growth and Income VCT plc (the “Companies”) announce that they have today published a Prospectus (comprising a Securities Note, Registration Document and Summary) in respect of an offer for subscription to raise up to £40,000,000 by way of an issue of new ordinary shares ("New Ordinary Shares") in the Companies, each raising up to £20,000,000, with an over-allotment facility of up to a further £20,000,000 in aggregate (being up to £10,000,000 for each of the Companies), payable in full in cash on application (the “Offer”).

The Offer opens on 3 December 2020 and will close not later than 5.00 p.m. on 31 March 2021 in respect of the 2020/2021 Offer and not later than 5.00 p.m. on 30 April 2021 in respect of the 2021/2022 Offer, or as soon as the Offer is fully subscribed. The directors of each of the Companies may decide to extend the Offer in respect of their Company at their absolute discretion to a date no later than 19 November 2021.

Applicants (and their spouses) who had an existing shareholding in one of the Companies on 3 December 2020, and whose valid Application forms part of the first £5 million of valid Applications for each Company and is received by 1 p.m. on 1 February 2021, will be entitled to additional New Ordinary Shares with an aggregate subscription price equivalent to 1.5% of the amount subscribed. 

All other Applicants whose valid Application forms part of the first £5 million of valid Applications for each Company and is received by 1 p.m. on 1 February 2021 will be entitled to additional New Ordinary Shares with an aggregate subscription price equivalent to 0.75% of the amount subscribed.

The subscription price of the additional New Ordinary Shares to be received by early applicants will be met by Beringea LLP, the Companies' investment manager ("Beringea").

Pursuant to an agreement dated 3 December 2020 between, inter alia, the Companies and Beringea LLP, Beringea will receive a fee (the "Fee") for acting as promoter of the Offer equal to five and a half (5.5) per cent. of the gross funds raised under the Offer from applications received directly from investors and three (3) per cent. of the gross funds raised under the Offer from applications received through a financial adviser or an execution-only brokers. Out of the Fee Beringea will pay all costs, agreed between the Companies and Beringea, including charges and expenses, of or incidental to the Offer.

Pursuant to a deed of variation dated 3 December 2020, the investment management agreement (the "ProVen IMA") between ProVen VCT plc and Beringea will be varied as a result of the Offer to provide for an increase in the compensation payable to Beringea in the event of an early termination of the ProVen IMA. The maximum amount of such additional compensation payable is £1,150,000, payable until 29 February 2024.

Pursuant to a deed of variation dated 3 December 2020, the investment management agreement (the "PGI IMA") between ProVen Growth & Income VCT plc and Beringea will be varied as a result of the Offer to provide for an increase in the compensation payable to Beringea in the event of an early termination of the PGI IMA. The maximum amount of such compensation payable is £1,600,000, payable until 29 February 2024.

The Fee and the above amendments to the ProVen IMA and the PGI IMA are small related party transactions between each of the Companies and Beringea under Listing Rule 11.1.10R.

In addition to the related party transactions described above, Malcolm Moss, a director of both Companies intends to invest £25,000 in each of the Companies under the Offer. Beringea is an associate of Mr Moss under the Listing Rules and, accordingly, the payment of the Fee and the above amendments to the ProVen IMA and the PGI IMA are required under the Listing Rules to be aggregated with Mr Moss's intended subscriptions. On an aggregated basis all of these proposed transactions are small related party transactions between Mr Moss and each of the Companies under Listing Rule 11.1.10R.

To obtain a copy of the Securities Note, investors and Financial Advisers should call the investment manager, Beringea, on 020 7845 7820. A downloadable version of the Securities Note is also available from www.provenvcts.co.uk.

A copy of the Prospectus is available, free of charge, from the registered office of the Companies or from:

Beringea LLP39 Earlham StreetLondon WC2H 9LT

If the registered office or Beringea’s office is closed due to government restrictions, copies may be requested via email to info@beringea.co.uk or by calling Beringea on 0207 845 7820.

Copies of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for viewing online at the following web-site address:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:Shane Elliott on 020 7845 7820Beringea LLPCompany SecretaryTelephone 020 7845 7820

Date   Source Headline
9th Apr 20191:20 pmGNWProVen VCT plc: Issue of Equity
5th Apr 201910:56 amGNWProVen VCT plc: Issue of Equity
1st Apr 20199:56 amGNWProVen VCT plc: Total voting rights
29th Mar 20194:29 pmGNWProVen VCT plc: Issue of Equity
28th Mar 20194:20 pmGNWProVen VCT plc: Statement re Offer for Subscription - Intention to Utilise Over-Allotment Facility
22nd Mar 20195:19 pmGNWProVen VCT plc: Issue of Equity
6th Mar 201912:11 pmGNWProVen VCT plc: Director/PDMR Shareholding
1st Mar 20195:50 pmGNWProVen VCT plc: Issue of Equity
1st Mar 201911:06 amGNWProVen VCT plc: Total voting rights
28th Feb 20195:27 pmGNWProVen VCT plc: Transaction in Own Shares
28th Jan 20196:11 pmGNWProVen VCT plc: Statement re Offer for Subscription - Additional Shares under the Offer
28th Jan 20193:07 pmGNWProVen VCT plc: Interim Management Statement
25th Jan 201912:31 pmGNWProVen VCT plc: Statement re Offer for Subscription – Additional Shares under the Offer
11th Jan 20195:00 pmGNWStatement re Offer for Subscription
2nd Jan 20199:00 amGNWProVen VCT plc: Total voting rights
19th Dec 20184:37 pmGNWProVen VCT plc: Transaction in Own Shares
3rd Dec 20181:44 pmGNWProVen VCT plc: Total voting rights
30th Nov 20184:23 pmGNWProVen VCT plc: Issue of Equity
1st Nov 20183:05 pmGNWProVen VCT plc: Total voting rights
31st Oct 20184:54 pmGNWTransaction in Own Shares
29th Oct 20184:04 pmGNWDoc re. Half-Yearly Report to 31 August 2018
24th Oct 201812:27 pmGNWProVen VCT: Half-year report
22nd Oct 201811:53 amGNWStatement re Offer for Subscription
3rd Sep 20189:30 amGNWProVen VCT plc : Total voting rights
31st Aug 201811:48 amGNWProVen VCT plc : Transaction in own shares
6th Nov 20152:13 pmRNSHolding(s) in Company
6th Nov 20152:11 pmRNSHolding(s) in Company
25th Mar 20152:26 pmRNSHolding(s) in Company
17th Dec 20093:05 pmRNSResult of Meeting
17th Nov 200911:58 amRNSHolding(s) in Company
21st Nov 20082:37 pmRNSHolding(s) in Company
9th Apr 200812:08 pmRNSHolding(s) in Company
4th Feb 20085:37 pmRNSHolding(s) in Company
9th Jul 200711:45 amRNSHolding(s) in Company
31st May 20075:54 pmRNSIssue of Equity
18th Apr 200712:25 pmRNSIssue of Equity
10th Apr 200710:29 amRNSIssue of Equity
4th Apr 20073:01 pmRNSIssue of Equity
30th Mar 200711:30 amRNSIssue of Equity
20th Mar 20075:57 pmRNSIssue of Equity
15th Mar 20077:02 amRNSDividend Declaration
7th Mar 200712:44 pmRNSIssue of Equity
1st Mar 20075:31 pmRNSTotal Voting Rights
28th Feb 20075:21 pmRNSTransaction in Own Shares
31st Jan 20075:05 pmRNSTransaction in Own Shares
25th Jan 20075:48 pmRNSDirectorate Change
12th Jan 20073:50 pmRNSTransaction in Own Shares
21st Dec 20065:28 pmRNSTotal Voting Rights
20th Dec 20064:20 pmRNSEGM Statement
17th Nov 20065:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.